• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性荨麻疹的时间依赖性效应:奥马珠单抗治疗的时间序列观察。

Time-Dependent Effects in Chronic Urticaria: A Time-Series Perspective of Omalizumab Treatment.

机构信息

First Department of Dermatology and Venereology, "Andreas Syggros" Hospital, National and Kapodistrian University of Athens, Medical School, Ionos Dragoumi 5, 11621, Athens, Greece.

First Department of Pediatrics, Choremeio Research Laboratory, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527, Goudi, Athens, Greece.

出版信息

Endocr Metab Immune Disord Drug Targets. 2020;20(10):1726-1739. doi: 10.2174/1871530320666200313151720.

DOI:10.2174/1871530320666200313151720
PMID:32167432
Abstract

BACKGROUND

Chronic spontaneous urticaria (CSU, or CU) is a disease that significantly affects the quality of life of patients. It is a chronic disease and requires a specialized approach to diagnosis and treatment. In recent years, the disease has been of great interest due to the existence of new targeted therapeutic approaches.

AIM

The present study aims at analyzing CU score concerning time, as a time-series. The authors have attempted to model the investigated time-series to unravel possible causative relationships.

METHODS

108 patients (25Males/83Females) admitted to our department were diagnosed with CU. CU was estimated on a score basis, which was used to define disease severity. Urticaria score was assessed on the basis of Urticaria Activity Score 7 (UAS7). The mean CU score, the mean CU score rate concerning the first month at diagnosis as well as the monthly CU score rate were calculated.

RESULTS

Gender is a factor that influences CU score with time. In addition, there was a significant finding that time-series differ with the administration of monotherapy or complementary therapy.

CONCLUSION

We have found that females are more prone to CU, while omalizumab monotherapy has more beneficial results as compared to the application of concurrent and maintenance therapies. Further, patients with co-morbidities were more likely to interrupt treatment. Finally, and most significantly, it was shown that monthly CU score rate manifested an oscillatory pattern, which was modelled with the sum of sines functions, highlighting a relative immunological pattern.

摘要

背景

慢性自发性荨麻疹(CSU,或 CU)是一种严重影响患者生活质量的疾病。它是一种慢性病,需要专门的方法进行诊断和治疗。近年来,由于存在新的靶向治疗方法,该疾病引起了极大的关注。

目的

本研究旨在分析 CU 评分随时间的变化,作为时间序列。作者试图对所研究的时间序列进行建模,以揭示可能的因果关系。

方法

我们部门收治了 108 名患者(25 名男性/83 名女性),诊断为 CU。CU 采用评分进行评估,用于定义疾病严重程度。荨麻疹评分基于荨麻疹活动评分 7(UAS7)进行评估。计算 CU 平均评分、诊断后第一个月的 CU 平均评分率以及每月 CU 评分率。

结果

性别是影响 CU 评分随时间变化的一个因素。此外,还有一个重要发现,即时间序列因单一疗法或补充疗法的应用而有所不同。

结论

我们发现女性更容易患 CU,而奥马珠单抗单药治疗比联合和维持治疗的效果更好。此外,合并症患者更有可能中断治疗。最后,也是最重要的一点,表明每月 CU 评分率表现出振荡模式,通过正弦函数的和进行建模,突出了相对免疫模式。

相似文献

1
Time-Dependent Effects in Chronic Urticaria: A Time-Series Perspective of Omalizumab Treatment.慢性荨麻疹的时间依赖性效应:奥马珠单抗治疗的时间序列观察。
Endocr Metab Immune Disord Drug Targets. 2020;20(10):1726-1739. doi: 10.2174/1871530320666200313151720.
2
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.奥马珠单抗治疗慢性荨麻疹:药物联合用药和合并症的影响。
Antiinflamm Antiallergy Agents Med Chem. 2021;20(1):39-50. doi: 10.2174/1871523019666200203123734.
3
Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.奥马珠单抗单药或联合治疗慢性自发性荨麻疹的有效性和安全性的真实世界数据:一项回顾性队列研究。
J Dermatolog Treat. 2020 Mar;31(2):204-209. doi: 10.1080/09546634.2019.1589639. Epub 2019 Mar 7.
4
Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience.奥马珠单抗治疗三级中心慢性自发性荨麻疹的经验:真实世界的经验。
Cutan Ocul Toxicol. 2020 Sep;39(3):249-253. doi: 10.1080/15569527.2020.1787432. Epub 2020 Jul 7.
5
Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.奥马珠单抗治疗慢性自发性荨麻疹的疗效评估:一项前瞻性研究。
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1761-1767. doi: 10.1111/jdv.15045. Epub 2018 May 29.
6
Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.奥马珠单抗治疗慢性自发性和诱导性荨麻疹:葡萄牙一项为期9年的回顾性研究。
Eur Ann Allergy Clin Immunol. 2018 Jul;50(4):169-176. doi: 10.23822/EurAnnACI.1764-1489.51. Epub 2018 Jan 16.
7
Efficacy and Safety of Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.奥马珠单抗治疗慢性自发性荨麻疹的疗效与安全性:随机对照试验的系统评价和荟萃分析
Am J Ther. 2020 Sep/Oct;27(5):e455-e467. doi: 10.1097/MJT.0000000000000912.
8
Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.抗组胺药耐药性慢性自发性荨麻疹仍治疗不足:来自 AWARE 研究的 2 年数据。
Clin Exp Allergy. 2020 Oct;50(10):1166-1175. doi: 10.1111/cea.13716. Epub 2020 Sep 3.
9
Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.慢性荨麻疹治疗优化后患者结局的改善:法国作为国际真实世界 AWARE 研究一部分的两年数据。
Eur J Dermatol. 2021 Apr 1;31(2):217-224. doi: 10.1684/ejd.2021.4023.
10
Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.英国真实临床实践环境中的慢性荨麻疹:非干预性多中心 AWARE 研究结果。
Clin Exp Dermatol. 2020 Dec;45(8):1003-1010. doi: 10.1111/ced.14230. Epub 2020 Aug 26.

引用本文的文献

1
Is there a difference between women and men in chronic spontaneous urticaria? A systematic review on gender and sex differences in CSU patients.慢性自发性荨麻疹在女性和男性之间存在差异吗?关于慢性自发性荨麻疹患者性别差异的系统评价。
World Allergy Organ J. 2024 Oct 12;17(11):100974. doi: 10.1016/j.waojou.2024.100974. eCollection 2024 Nov.